Abstract: The January 29, 2021, issue of the U.S. Food and Drug Administration's (FDA) NCTR Research Highlights includes an item highlighting the National Center for Toxicological Research's (NCTR) nanotechnology-related activities in 2020. January 29th, 2021 FDA's NCTR Highlights Its Nanotechnology-Related Activities in 2020 The January 29, 2021, issue of the U.S. Food and Drug Administration's (FDA) NCTR Research Highlights includes an item highlighting the National Center for Toxicological Research's (NCTR) nanotechnology-related activities in 2020. See https://www.fda.gov/about-fda/nctr-publications/nctr-research-highlights The activities include: - Nanotechnology Standards: Two work items developed by the NCTR Nanotechnology Core Facility (Nanocore) staff became standards in February 2019 and January 2020 (Standard Practice for Performing Cryo-Transmission Electron Microscopy of Liposomes and Standard Test Method for Quantitative Measurement of the Chemoattractant Capacity of a Nanoparticulate Material in vitro, respectively) and are available through ASTM International. See https://www.astm.org/Standards/E3143.htm and https://www.astm.org/Standards/E3238.htm Seven additional work items developed by the NCTR Nanocore scientists are going through the consensus-standard process at ASTM International E56 for quality assurance and testing for biocompatibility;